(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 5.31% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Lantheus Holdings's revenue in 2025 is $1,520,653,000.On average, 4 Wall Street analysts forecast LNTH's revenue for 2025 to be $100,712,933,499, with the lowest LNTH revenue forecast at $100,313,127,903, and the highest LNTH revenue forecast at $101,290,883,765. On average, 6 Wall Street analysts forecast LNTH's revenue for 2026 to be $108,941,993,376, with the lowest LNTH revenue forecast at $96,075,732,537, and the highest LNTH revenue forecast at $117,881,456,121.
In 2027, LNTH is forecast to generate $121,421,231,518 in revenue, with the lowest revenue forecast at $114,094,182,022 and the highest revenue forecast at $127,380,238,737.